Clinical Trial Update: Comparison of Lactobacillus Reuteri and Nystatin Prophylaxis on Candida Colonization and Infection in Very Low Birth Weight Infants [Phase 4]

View source ↗

Summary

Clinical trial update for a Phase 4 study comparing Lactobacillus reuteri to Nystatin prophylaxis in very low birth weight infants to prevent Candida colonizati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Candida Infections in Neonates
• Neonatal Candidiasis

Drugs mentioned

• Lactobacillus reuteri (Lactobacillus reuteri)
• Nystatin (Nystatin)

Snippet

Sponsor: Zekai Tahir Burak Women's Health Research and Education Hospital | Conditions: Very Low Birth Weight Infants | Phase 4 | Status: COMPLETED